According to the TCGA and GTEx data, both CCL5 and SERPIN E1 were expressed at significantly higher levels in pancreatic cancer tissues (T, n = 179) than in nearby normal pancreatic tissues (N, n = 171) (Fig. 7f, i). The gene discussed is CCL5; the disease is familial pancreatic carcinoma.